1. ScholarBank@NUS

Cheng Chuan Lee

rp03743

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Cheng Chuan Lee
Variants
Cheng, C.L.
Lee, C.C.
 
Main Affiliation
 
Faculty
 
Email
mdclcc@nus.edu.sg
 

Publications

Results 1-6 of 6 (Search time: 0.004 seconds).

Issue DateTitleAuthor(s)
1May-2008Building partnerships to address the HIV epidemicChua, A.C.; Leo, Y.S.; Lee, C.C. 
22020Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adultsHo, S.; Wong, J.G.; Ng, O.T.; Lee, C.C. ; Leo, Y.S. ; Lye, D.C.B. ; Wong, C.S. 
3Jul-2008Healthcare workers and HIV health issuesChua, A.; Yee, S.L.; Kurup, A.; Chlebicki, M.P.; Cheng, C.L. 
42011Increased rate of CD4+ T-Cell decline and faster time to antiretroviral therapy in HIV-1 subtype CRF01_AE infected seroconverters in singaporeNg O.T. ; Lin L.; Laeyendecker O.; Quinn T.C.; Sun Y.J.; Lee C.C. ; Leo Y.S. 
5Jun-2009Management of novel influenza epidemics in Singapore: Consensus recommendations from the Hospital Influenza Workgroup (Singapore)Ang, B.; Archuleta, S. ; Chiew, Y.F.; Chlebicki, M.P.; Chua, A.; Fisher, D.A. ; Hsu, L.Y.; Kang, M.L.; Koh, Y.L.; Kurup, A. ; Lee, C.C. ; Leo, Y.S. ; Leong, H.N.; Lim, P.L.; Ling, L.M.; Ling, M.L. ; Lye, D.C.B.; Tambyah, P. ; Tan, T.T. ; Wilder-Smith, A. 
61-Nov-2021Safety and effectiveness of switching to Abacavir/Lamivudine plus rilpivirine for maintenance therapy in virologically suppressed HIV-1 individuals in Singapore (SEALS)Lim, Z. C.; Hoo, G. S.; Ang, J. H.; Teng, C. B. ; Ang, L. W.; Lee, C. C. ; Leo, Y. S. ; Law, H. L.; Ng, O. T.; Wong, C. S.